Wen Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wen Zhang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Ting Wu
Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
2 shared publications- Yifei Li
Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China
2 shared publications Bo Jiang
Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China
1 shared publication- Dan Liu
Department of Ultrasound, Medical Imaging Center, West China Second University Hospital, Chengdu, China
1 shared publication He Huang
Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China
1 shared publication- Hong Luo
Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
1 shared publication
Latest Publications
- 2 December 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (5) , 2276-2278
Use of Saline Echocardiography in Diagnosing Functional Pulmonary Atresia in A Newborn
This case report details a neonate with functional pulmonary atresia (FPA), initially misdiagnosed prenatally as anatomical pulmonary atresia. Fetal findings included cardiomegaly, severe tricuspid regurgitation, and right ventricular dysfunction. Postnatally, the absence of antegrade pulmonary flow raised concern for anatomical atresia. However, saline contrast echocardiography definitively confirmed patent pulmonary valves, establishing the diagnosis of transient FPA secondary to severe functional right heart impairment without anatomical atresia of the pulmonary valves. This case highlights the potential value of the saline contrast test in distinguishing FPA from anatomical pulmonary atresia, which can help avoid unnecessary interventions. It also provides additional insight into the natural history of prenatally suspected isolated FPA.
- 2 December 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (5) , 2276-2278
Use of Saline Echocardiography in Diagnosing Functional Pulmonary Atresia in A Newborn
This case report details a neonate with functional pulmonary atresia (FPA), initially misdiagnosed prenatally as anatomical pulmonary atresia. Fetal findings included cardiomegaly, severe tricuspid regurgitation, and right ventricular dysfunction. Postnatally, the absence of antegrade pulmonary flow raised concern for anatomical atresia. However, saline contrast echocardiography definitively confirmed patent pulmonary valves, establishing the diagnosis of transient FPA secondary to severe functional right heart impairment without anatomical atresia of the pulmonary valves. This case highlights the potential value of the saline contrast test in distinguishing FPA from anatomical pulmonary atresia, which can help avoid unnecessary interventions. It also provides additional insight into the natural history of prenatally suspected isolated FPA.
- Open Access
- 15 May 2025
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1589038
The molecular mechanisms of IUGR programmed adulthood cardiovascular disease
Intrauterine growth restriction (IUGR) is secondary to several maternal and fetal adverse conditions. Recently, there is a convincing association between the onset of IUGR and adulthood programmed complications. Among them, the disorders in the cardiovascular system have been revealed by a series of researches. Currently, the prevalence of IUGR is considered to be related to programmed hypertension, coronary artery lesions, pulmonary hypertension, metabolic dysfunction, and even heart failure. According to the emerging knowledge in this field, the experiences of IUGR would induce prolonged inflammation, oxidative injuries, aberrant metabolites and epigenetic regulation, which resulted in endothelial, smooth muscle cells and cardiomyocytes damages. In this review, we summarized the evidences and progress in establishing the association between IUGR and programmed cardiovascular diseases and involved molecular mechanisms. Furthermore, we also discussed the potential efficient therapeutic strategies. This comprehensive review demonstrated that IUGR manifested long-term consequences persisting into adulthood through multifaceted molecular pathways, notably oxidative stress mechanisms, mitochondrial dysfunction, and epigenetic alterations. These findings underscored the critical importance of implementing early preventive interventions and developing personalized therapeutic approaches in future clinical practice.
- 15 May 2025
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1589038
Open AccessThe molecular mechanisms of IUGR programmed adulthood cardiovascular disease
Intrauterine growth restriction (IUGR) is secondary to several maternal and fetal adverse conditions. Recently, there is a convincing association between the onset of IUGR and adulthood programmed complications. Among them, the disorders in the cardiovascular system have been revealed by a series of researches. Currently, the prevalence of IUGR is considered to be related to programmed hypertension, coronary artery lesions, pulmonary hypertension, metabolic dysfunction, and even heart failure. According to the emerging knowledge in this field, the experiences of IUGR would induce prolonged inflammation, oxidative injuries, aberrant metabolites and epigenetic regulation, which resulted in endothelial, smooth muscle cells and cardiomyocytes damages. In this review, we summarized the evidences and progress in establishing the association between IUGR and programmed cardiovascular diseases and involved molecular mechanisms. Furthermore, we also discussed the potential efficient therapeutic strategies. This comprehensive review demonstrated that IUGR manifested long-term consequences persisting into adulthood through multifaceted molecular pathways, notably oxidative stress mechanisms, mitochondrial dysfunction, and epigenetic alterations. These findings underscored the critical importance of implementing early preventive interventions and developing personalized therapeutic approaches in future clinical practice.
- Open Access
- 20 April 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14
The molecular mechanisms in prenatal drug exposure-induced fetal programmed adult cardiovascular disease
The “developmental origins of health and disease” (DOHaD) hypothesis posits that early-life environmental exposures have a lasting impact on individual’s health and permanently shape growth, structure, and metabolism. This reprogramming, which results from fetal stress, is believed to contribute to the development of adulthood cardiovascular diseases such as hypertension, coronary artery disease, heart failure, and increased susceptibility to ischemic injuries. Recent studies have shown that prenatal exposure to drugs, such as glucocorticoids, antibiotics, antidepressants, antiepileptics, and other toxins, increases the risk of adult-onset cardiovascular diseases. In addition, observational and animal experimental studies have demonstrated the association between prenatal drug exposure and the programming of cardiovascular disease in the offspring. The molecular mechanisms underlying these effects are still being explored but are thought to involve metabolism dysregulation. This review summarizes the current evidence on the relationship between prenatal drug exposure and the risk of adult cardiovascular disorders. Additionally, we present the latest insights into the molecular mechanisms that lead to programmed cardiovascular phenotypes after prenatal drug exposure.
- 20 April 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14
Open AccessThe molecular mechanisms in prenatal drug exposure-induced fetal programmed adult cardiovascular disease
The “developmental origins of health and disease” (DOHaD) hypothesis posits that early-life environmental exposures have a lasting impact on individual’s health and permanently shape growth, structure, and metabolism. This reprogramming, which results from fetal stress, is believed to contribute to the development of adulthood cardiovascular diseases such as hypertension, coronary artery disease, heart failure, and increased susceptibility to ischemic injuries. Recent studies have shown that prenatal exposure to drugs, such as glucocorticoids, antibiotics, antidepressants, antiepileptics, and other toxins, increases the risk of adult-onset cardiovascular diseases. In addition, observational and animal experimental studies have demonstrated the association between prenatal drug exposure and the programming of cardiovascular disease in the offspring. The molecular mechanisms underlying these effects are still being explored but are thought to involve metabolism dysregulation. This review summarizes the current evidence on the relationship between prenatal drug exposure and the risk of adult cardiovascular disorders. Additionally, we present the latest insights into the molecular mechanisms that lead to programmed cardiovascular phenotypes after prenatal drug exposure.
- 1 May 2021
- Vol. 52 (3) , 528-530
碘普罗胺诱发脑病1例报告
患者,男,42岁,因“发作性晕厥10+个月,胸闷20+ d,胸痛10+ d”入院。诊断为肥厚型心肌病,既往无高血压、糖尿病病史。为了解左室流出道压差及冠脉情况,予以左室心导管检查及冠脉造影术,心导管经右侧桡动脉入路,共使用碘质量浓度为370 mg I/mL的碘普罗胺200 mL,术后患者出现以剧烈头痛、皮质盲、神经精神症状为主要临床表现的造影剂脑病。予以降颅压、镇静及止痛等对症支持治疗,患者自愈。
- 1 May 2021
- Vol. 52 (3) , 528-530
碘普罗胺诱发脑病1例报告
患者,男,42岁,因“发作性晕厥10+个月,胸闷20+ d,胸痛10+ d”入院。诊断为肥厚型心肌病,既往无高血压、糖尿病病史。为了解左室流出道压差及冠脉情况,予以左室心导管检查及冠脉造影术,心导管经右侧桡动脉入路,共使用碘质量浓度为370 mg I/mL的碘普罗胺200 mL,术后患者出现以剧烈头痛、皮质盲、神经精神症状为主要临床表现的造影剂脑病。予以降颅压、镇静及止痛等对症支持治疗,患者自愈。